The US Supreme Court has preserved country-wide access to the abortion pill mifepristone by post, blocking lower court restrictions that would have sharply curtailed the ability to obtain the drug at home.
The ruling means women across America can continue receiving abortion pills through pharmacies and telemedicine services while a major legal challenge brought by the state of Louisiana continues through the courts.
The case centres on whether the Food and Drug Administration acted lawfully when it permanently allowed mifepristone to be prescribed online and delivered through the post, a policy first introduced during the COVID-19 pandemic. Louisiana argued the move undermined the state’s abortion laws following the fall of Roe v Wade.
Two conservative justices, Clarence Thomas and Samuel Alito, issued strong dissents warning that the Court’s decision risks hollowing out state abortion protections.
Justice Thomas accused abortion pill manufacturers of seeking protection for “lost profits from their criminal enterprise,” arguing they could not claim legal harm from restrictions that made alleged unlawful activity more difficult. Justice Alito warned that the ruling allows efforts to undermine the Dobbs decision, which returned abortion law to individual states, to continue unchecked.
The legal battle has highlighted the increasingly organised efforts by abortion activists to maintain access to abortion drugs regardless of state laws. During a brief period when a lower court temporarily halted mail distribution of mifepristone, abortion providers immediately moved to alternative methods to continue abortions by post.
Massachusetts physician Dr Angel Foster admitted her organisation switched women to “misoprostol-only” abortion regimens as soon as the restrictions were announced. Misoprostol, typically used alongside mifepristone, can also induce abortions on its own, although studies show it has a higher failure rate and can cause more intense side effects including severe bleeding, cramping, fever, nausea, diarrhoea, and incomplete abortions requiring hospital treatment.
Despite those risks, Foster insisted abortion pills would continue to be distributed “in all 50 states” no matter what courts ultimately decide.
Abortion activists have also openly discussed contingency plans to source pills internationally if US courts tighten restrictions further. Dutch abortion group Aid Access has said it could send abortion drugs from India, while campaigners have encouraged women to stockpile abortion pills in anticipation of future legal battles.
This exposes the dangers of increasingly deregulated “pills by post” abortion schemes, which remove in-person medical oversight and make it easier for women to undergo abortions without proper safeguarding or screening. Concerns have also been raised about complications linked to chemical abortions, with an FOI in Britain by SPUC showing one in 17 women requiring hospital treatment after taking abortion pills at home.
Commenting on the developments, SPUC Executive Director, Michael Robinson, said, “Abortion campaigners are clearly determined to bypass legal protections for unborn children no matter what. This is no reason to retreat, but a reason to make the law clearer in its protection of unborn children. Whilst the condemnation from Clarence Thomas is welcome, President Trump and Congress must commit to banning the abortion pill through legislation, not just through the courts.
“The West will never prosper whilst allowing the destruction of the next generation in their most vulnerable state. The legislative route to end abortion is one that cannot be forgotten, and the Americans are in a place to pursue it. They must.”
